LPL Financial’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

LPL Financial’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-96,456	Closed	-$41K	–	2876
2016 Q3	$41K	Sell	96,456 -3,000	-3%	-$1.37K	﹤0.01%	2586
2016 Q2	$49K	Sell	99,456 -100,202	-50%	-$107K	﹤0.01%	2563
2016 Q1	$299K	Sell	199,658 -1,000	-0.5%	-$1.97K	﹤0.01%	2514
2015 Q4	$612K	Buy	200,658 +99,329	+98%	+$478K	﹤0.01%	2064
2015 Q3	$671K	Sell	101,329 -4,250	-4%	-$39.7K	﹤0.01%	1549
2015 Q2	$1.06M	Buy	105,579 +9,594	+10%	+$84K	0.01%	1323
2015 Q1	$701K	Buy	95,985 +11,000	+13%	+$74K	﹤0.01%	1612
2014 Q4	$455K	Buy	84,985 +4,543	+6%	+$23.2K	﹤0.01%	1836
2014 Q3	$389K	Buy	80,442 +9,100	+13%	+$55.9K	﹤0.01%	1976
2014 Q2	$479K	Buy	+71,342	New	+$454K	﹤0.01%	1835

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

MBT

Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

LPL Financial's NWBO Position: Q4 2016 in Review

LPL Financial sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 96,456 shares — an estimated $41K sold.

LPL Financial first reported a position in NWBO in Q2 2014 and held it in 10 quarters. The position peaked at $1.06M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

LPL Financial reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
LPL Financial sold 96,456 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $41K.
LPL Financial first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 10 quarters.
LPL Financial's Northwest Biotherapeutics, Inc. Common stock position peaked at $1.06M in Q2 2015.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.